Wells Fargo & Company Ark Genomic Revolution ETF (De Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Wells Fargo & Company holds 997,089 shares of ARKG stock, worth $26.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
997,089
Previous 1,086,947
8.27%
Holding current value
$26.8 Million
Previous $26.5 Million
4.62%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio